无肌层浸润的I期2级及浅肌层浸润的1-2级子宫内膜癌患者保留生育功能的激素治疗:妇科肿瘤研究研究者协作研究(GORILLA-2001)
这项多中心研究分析了2005至2021年间接受保留生育功能激素治疗的54例I期2级无肌层浸润或1-2级浅肌层浸润子宫内膜癌患者,完全缓解率为72.2%,完全缓解后尝试妊娠者中46.7%妊娠,但16.6%出现疾病进展,肿瘤大小≥2 cm与疾病进展风险升高相关。
要点
- 54例患者接受孕激素保留生育功能治疗,39例(72.2%)达完全缓解,中位至完全缓解时间10个月。
- 15例尝试妊娠者中7例(46.7%)妊娠,其中5例活产、2例流产。
- 肿瘤大小≥2 cm与治疗期间疾病进展风险升高显著相关(HR 5.456)。
核心结论
- 保留生育功能激素治疗的总体缓解率令人鼓舞,但治疗最初12个月内疾病进展率显著。
- 作者认为从治疗开始每3个月进行全面的子宫内膜活检和影像学检查对严格评估病变范围至关重要。
研究设计与样本
- 多中心研究,分析2005年至2021年间接受保留生育功能激素治疗的I期2级无肌层浸润或1-2级浅肌层浸润子宫内膜癌患者54例。
主要发现
- 54例患者中44例接受甲羟孕酮(500-1000 mg),10例接受甲地孕酮(40-800 mg),31例同时使用左炔诺孕酮宫内缓释系统。
- 39例(72.2%)达到完全缓解,中位至完全缓解时间为10(3-24)个月。
- 中位保留生育功能治疗时长6(3-12)个月期间,9例(16.6%)诊断为疾病进展。
- 15例(38.5%)出现复发,中位无复发生存期为23(3-101)个月。
- 完全缓解后尝试妊娠的15例中7例(46.7%)妊娠,其中2例流产、5例活产。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate oncologic and pregnancy outcomes of fertility-sparing treatment (FST) using progestin in patients with stage I grade 2 endometrioid endometrial cancer (EC) without myometrial invasion (MI) or grade 1-2 with superficial MI. METHODS: Multicenter data of patients with stage I grade 2 EC without MI or grade 1-2 EC with superficial MI, who received FST between 2005 and 2021, were analyzed. Cox regression analysis identified independent factors for progressive disease (PD) during the FST. RESULTS: Altogether, 54 patients received FST [medroxyprogesterone acetate (500-1000 mg) in 44, megestrol acetate (40-800 mg) in 10] with concurrent levonorgestrel-releasing intrauterine devices use in 31. With median time to achieve a complete response (CR) of 10 (3-24) months, 39 patients (72.2%) achieved CR. Of the 15 patients who attempted to conceive after achieving CR, 7 (46.7%) became pregnant (2 abortions, 5 live births). During a median FST duration of 6 (3-12) months, nine patients (16.6%) were diagnosed with PD. Fifteen (38.5%) experienced recurrence with a median recurrence-free survival of 23 (3-101) months. In the multivariable analysis, tumor size before FST ≥2 cm (HR 5.456, 95% CI 1.34 to 22.14; p = 0.018) was significantly associated with a high PD rate during FST. CONCLUSION: The overall response rate to FST was promising, however, the PD rate was significant during the first 12 months of FST. Therefore, performing thorough endometrial biopsy and imaging studies is essential to strictly evaluate the extent of the disease every 3 months from FST initiation.
引用
- Lee AJ, Yang EJ, Kim NK, et al. Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001). Gynecol Oncol. 2023. PMID: 37172410. doi:10.1016/j.ygyno.2023.04.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。